Cargando…
Obeticholic acid and ferrostatin-1 differentially ameliorate non-alcoholic steatohepatitis in AMLN diet-fed ob/ob mice
Introduction: Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are common chronic liver diseases with limited treatment options. Methods: Ob/ob mice (6 weeks old) were fed with the Control diet or amylin liver NASH (AMLN) diet for 24 weeks to establish the NASH, the...
Autores principales: | Li, Shengjie, Zhuge, Aoxiang, Wang, Kaicen, Xia, Jiafeng, Wang, Qiangqiang, Han, Shengyi, Shen, Jian, Li, Lanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800415/ https://www.ncbi.nlm.nih.gov/pubmed/36588706 http://dx.doi.org/10.3389/fphar.2022.1081553 |
Ejemplares similares
-
Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice
por: Zhuge, Aoxiang, et al.
Publicado: (2022) -
Abdominal Irradiation Ameliorates Obesity in ob/ob Mice
por: Okada, Sumiyo, et al.
Publicado: (2007) -
Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice
por: Kim, Kyung Eun, et al.
Publicado: (2023) -
Deferoxamine ameliorates adipocyte dysfunction by modulating iron metabolism in ob/ob mice
por: Yan, Hong-Fa, et al.
Publicado: (2018) -
Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH
por: Roth, Jonathan D., et al.
Publicado: (2019)